• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

横纹肌肉瘤治疗中使用的细胞抑制剂化合物的天然起源。

The natural origins of cytostatic compounds used in rhabdomyosarcoma therapy.

机构信息

Department of Animal Developmental Biology, Faculty of Biological Sciences, University of Wrocław, Poland.

Department of Molecular and Cellular Biology, Faculty of Pharmacy, Wroclaw Medical University, Poland.

出版信息

Adv Clin Exp Med. 2023 Oct;32(10):1179-1191. doi: 10.17219/acem/161165.

DOI:10.17219/acem/161165
PMID:36920267
Abstract

Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children and represents a high-grade neoplasm of skeletal myoblast-like cells. About 40% of all registered soft tissue tumors are RMSs. This paper describes our current understanding of the RMS subtypes (alveolar (ARMS), embryonic (ERMS), pleomorphic (PRMS), and spindle cell/sclerosing (s/scRMS)), diagnostic methods, molecular bases, and characteristics. We also present the currently used treatment methods and the potential use of natural substances in the treatment of this type of cancer. Natural cytotoxic substances are compounds that have been the subject of numerous studies and discussions in recent years. Since anti-cancer therapies are often limited by a low therapeutic index and cancer resistance to pharmacotherapy, it is very important to search for new, effective compounds. Additionally, compounds of a natural origin are usually readily available and have a reduced cytotoxicity. Thus, the undiscovered potential of natural anti-cancer compounds makes this field of research a very important area. The introduction of model species into research examining the use of natural cytostatic therapies for RMS will allow for further assessment of the effects of these compounds on cancerous and healthy tissues.

摘要

横纹肌肉瘤(RMS)是儿童中最常见的软组织肉瘤,代表了骨骼肌母细胞样细胞的高级别肿瘤。约 40%的所有已登记的软组织肿瘤是 RMS。本文介绍了我们目前对 RMS 亚型(肺泡(ARMS)、胚胎(ERMS)、多形性(PRMS)和梭形细胞/硬化(s/scRMS))、诊断方法、分子基础和特征的理解。我们还介绍了目前使用的治疗方法以及天然物质在治疗这种癌症中的潜在用途。天然细胞毒性物质是近年来受到大量研究和讨论的化合物。由于抗癌疗法通常受到治疗指数低和癌症对化疗耐药性的限制,因此寻找新的、有效的化合物非常重要。此外,天然来源的化合物通常易于获得且细胞毒性较低。因此,天然抗癌化合物的未被发现的潜力使该研究领域成为一个非常重要的领域。将模式物种引入研究中,以评估天然细胞抑制剂疗法在 RMS 中的应用,将允许进一步评估这些化合物对癌变组织和健康组织的影响。

相似文献

1
The natural origins of cytostatic compounds used in rhabdomyosarcoma therapy.横纹肌肉瘤治疗中使用的细胞抑制剂化合物的天然起源。
Adv Clin Exp Med. 2023 Oct;32(10):1179-1191. doi: 10.17219/acem/161165.
2
Sclerosing rhabdomyosarcoma in adults: report of four cases of a hyalinizing, matrix-rich variant of rhabdomyosarcoma that may be confused with osteosarcoma, chondrosarcoma, or angiosarcoma.成人硬化性横纹肌肉瘤:4例报告,该横纹肌肉瘤为一种富含基质的透明变性变异型,可能会与骨肉瘤、软骨肉瘤或血管肉瘤相混淆。
Am J Surg Pathol. 2002 Sep;26(9):1175-83. doi: 10.1097/00000478-200209000-00008.
3
Are myogenin and myoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics.肌生成素和肌分化抗原1(MyoD1)的表达对横纹肌肉瘤具有特异性吗?一项对150例病例的研究,重点关注梭形细胞模仿物。
Am J Surg Pathol. 2001 Sep;25(9):1150-7. doi: 10.1097/00000478-200109000-00005.
4
Spindle cell rhabdomyosarcoma in adults: clinicopathological and immunohistochemical analysis of seven new cases.成人梭形细胞横纹肌肉瘤:7例新病例的临床病理及免疫组化分析
Virchows Arch. 2006 Nov;449(5):554-60. doi: 10.1007/s00428-006-0284-4. Epub 2006 Sep 30.
5
Clinicopathologic features of 300 rhabdomyosarcomas with emphasis upon differential expression of skeletal muscle specific markers in the various subtypes: A single institutional experience.300例横纹肌肉瘤的临床病理特征,重点关注不同亚型中骨骼肌特异性标志物的差异表达:单中心经验
Ann Diagn Pathol. 2018 Oct;36:50-60. doi: 10.1016/j.anndiagpath.2018.07.002. Epub 2018 Aug 3.
6
[Spindle cell rhabdomyosarcoma in adults: a new entity in the spectrum of malignant mesenchymal tumors of soft tissues].[成人梭形细胞横纹肌肉瘤:软组织恶性间叶肿瘤谱系中的一个新实体]
Pathologe. 2010 Mar;31(2):91-6. doi: 10.1007/s00292-009-1249-6.
7
Rhabdomyosarcoma: Updates on classification and the necessity of molecular testing beyond immunohistochemistry.横纹肌肉瘤:分类更新及免疫组织化学以外进行分子检测的必要性。
Hum Pathol. 2024 May;147:72-81. doi: 10.1016/j.humpath.2023.12.004. Epub 2023 Dec 21.
8
A clinicopathologic study of head and neck rhabdomyosarcomas showing FOXO1 fusion-positive alveolar and MYOD1-mutant sclerosing are associated with unfavorable outcome.一项关于头颈部横纹肌肉瘤的临床病理研究表明,FOXO1融合阳性的肺泡型和MYOD1突变的硬化型与不良预后相关。
Oral Oncol. 2016 Oct;61:89-97. doi: 10.1016/j.oraloncology.2016.08.017. Epub 2016 Sep 6.
9
Anaplasia in childhood rhabdomyosarcoma: An under reported entity.儿童横纹肌肉瘤中的间变:一个报道较少的实体。
Indian J Pathol Microbiol. 2022 Oct-Dec;65(4):864-868. doi: 10.4103/ijpm.ijpm_178_21.
10
Histopathological, immunohistochemical and molecular cytogenetic analysis of 21 spindle cell/sclerosing rhabdomyosarcomas.21例梭形细胞/硬化性横纹肌肉瘤的组织病理学、免疫组织化学及分子细胞遗传学分析
APMIS. 2014 Nov;122(11):1144-52. doi: 10.1111/apm.12272. Epub 2014 Apr 14.

引用本文的文献

1
Derivatization of Abietane Acids by Peptide-like Substituents Leads to Submicromolar Cytotoxicity at NCI-60 Panel.肽样取代基对枞酸衍生物的衍生化导致 NCI-60 小组的细胞毒性达到亚毫摩尔水平。
Molecules. 2024 Jul 27;29(15):3532. doi: 10.3390/molecules29153532.
2
Transforming Growth Factor Beta and Alveolar Rhabdomyosarcoma: A Challenge of Tumor Differentiation and Chemotherapy Response.转化生长因子β与肺泡横纹肌肉瘤:肿瘤分化与化疗反应的挑战。
Int J Mol Sci. 2024 Feb 28;25(5):2791. doi: 10.3390/ijms25052791.